Compare JYNT & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JYNT | DERM |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.7M | 135.3M |
| IPO Year | 2014 | 2021 |
| Metric | JYNT | DERM |
|---|---|---|
| Price | $8.58 | $4.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $17.00 | $12.67 |
| AVG Volume (30 Days) | 35.3K | ★ 320.7K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 133.93 | 34.72 |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $117,696,356.00 | $61,858,000.00 |
| Revenue This Year | $12.23 | $39.72 |
| Revenue Next Year | N/A | $63.24 |
| P/E Ratio | $46.58 | ★ N/A |
| Revenue Growth | ★ 15.49 | 10.20 |
| 52 Week Low | $7.50 | $4.31 |
| 52 Week High | $13.47 | $9.56 |
| Indicator | JYNT | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 45.23 | 35.29 |
| Support Level | $8.56 | $4.31 |
| Resistance Level | $8.67 | $8.12 |
| Average True Range (ATR) | 0.34 | 0.31 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 11.83 | 43.42 |
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.